Acute Therapies

Fresenius Medical Care’s product portfolio for Acute Kidney Injury supports treatment of your acute patients. As part of our commitment to ensuring optimal outcomes for all patients with AKI, we are now proud to offer Continuous Renal Replacement Therapies (CRRT) and Extended Daily Diafiltration (EDD-f).

multiFiltrate Ci-Ca^® offers Regional Citrate Anticoagulation Therapies.

Advantages of citrate anticoagulation:

• Preferred anticoagulation in CRRT in accordance with the KDIGO Clinical Practice Guideline for Acute Kidney Injury¹
• Prolonged filter patency compared with heparin anticoagulation
• Reduced bleeding risk due to regional anticoagulation
• Acid-base status adjustable³
  
  Advantages of Ci-Ca^® therapy with integrated Ci-Ca^® module:
  
• Reconnected citrate and calcium tubing’s clearly assigned on the cassette
• Colour coding for intuitive setup
• Different connectors for citrate and calcium to avoid mix-up of bags
• Citrate and calcium flow coupled with blood and filtrate flows
• Well suited set of disposables and solutions
  
  References:
  1. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Inter., Suppl. (2012)2, 1-138.
  2. Zhang Z, Hongying N: Efficacy and safety of regional citrate anticoagulation in critically ill patients undergoing continuous renal replacement therapy. Intensive Care Med 38:20-28, 2012.
  3. Morgera S et al.: A safe citrate anticoagulation protocol with variable treatment efficacy and excellent control of the acid-base status. Crit Care Med 37:2018-2024, 2009.